Manipal Hospitals Files for CCI Approval to Acquire Sahyadri Hospitals in Estimated ₹6,400 Crore Deal

IMT News Desk
IMT News Desk
· 2 min read

The acquisition will expand Manipal Hospitals’ national network to 49 hospitals and about 12,000 beds, strengthening its reach in western India.

Manipal Hospitals has filed a notice with the Competition Commission of India (CCI) seeking approval to acquire Pune-based Sahyadri Hospitals. The proposed deal, structured in multiple tranches, involves the acquisition of up to 100 percent shareholding in Sahyadri Hospitals Pvt Ltd. The deal value has not been officially disclosed by the companies, but industry sources estimate it between ₹6,200 and ₹6,400 crore.

According to The Economic Times, in the CCI filing, the companies stated that the proposed transaction would not affect the relevant market or lead to any appreciable adverse effect on competition in India. Both parties also suggested that the definition of relevant product and geographic markets could be left open for the regulator’s assessment.

Last month, Manipal Hospitals signed definitive agreements with Ontario Teachers’ Pension Plan Board, the current majority stakeholder in Sahyadri Hospitals. Ontario Teachers’, a global investor with net assets of USD 266.3 billion as of December 2024, acquired its stake in Sahyadri in 2022.

Post-acquisition, Manipal Hospitals will add 11 facilities located across Pune, Nashik, Ahilya Nagar, and Karad, bringing its total number of hospitals to 49. The deal will increase its national bed capacity to around 12,000. The expansion supports Manipal’s ongoing strategy to grow its presence in western India and strengthen its position as one of the country’s largest hospital networks.

Manipal Health Enterprises MD and CEO Dilip Jose noted that the acquisition aligns with the company’s plan to expand reach while continuing to deliver healthcare services across new geographies. Manipal Education and Medical Group (MEMG) Chairman Ranjan Pai added that the move will reinforce the group’s footprint in western India.

Manipal Hospitals is backed by Singapore-based global investment firm Temasek, which reported a portfolio value of approximately USD 324 billion as of March 2025. The addition of Sahyadri’s infrastructure and capacity is seen as a step toward building scale across diverse regional healthcare markets in India.

Read Next

Zydus Wellness net sales up by 62.1% for Q4 & 46.4% for FY 26  
News
May 19, 2026

Zydus Wellness net sales up by 62.1% for Q4 & 46.4% for FY 26  

Zydus Wellness Limited reported a consolidated growth of 62.1% in Net Sales, which stood at Rs. 14,761 million as compared to Rs. 9,106 million in the corresponding period of the previous year. The Company reported annual Net Sales of Rs. 39,400 million, with a y-o-y growth of 46.4% in FY 26. EBITDA for the period […]
Article by: IMT News Desk
Strides Pharma delivers strong FY26 performance with 50% PAT growth, ex‑US markets up 21%
News
May 19, 2026

Strides Pharma delivers strong FY26 performance with 50% PAT growth, ex‑US markets up 21%

Strides Pharma Science Ltd. reported a robust FY26 performance, with consolidated EBITDA rising to ₹9,253 crore and operational profit after tax (PAT) at ₹5,181 crore, up 50.3% year‑on‑year. The company’s ex‑US markets outpaced the rest of the business, posting 21% YoY revenue growth, while disciplined execution expanded full‑year EBITDA margin to 19%, up 140 basis points from FY25. […]
Article by: IMT News Desk
Annora Pharma Expands Collaboration with AI-Native Traceability Platform AltiusHub to Strengthen Global Drug Traceability
News
May 18, 2026

Annora Pharma Expands Collaboration with AI-Native Traceability Platform AltiusHub to Strengthen Global Drug Traceability

Annora Pharma, the formulations subsidiary of Hetero Group, has expanded its collaboration with AltiusHub. The company is deploying AltiusHub’s AI-native serialization, track & trace and regulatory compliance platform across its export operations. The deployment is designed to improve serialization efficiency by up to 45%. It will also strengthen operational visibility across Annora Pharma’s global supply […]
Article by: IMT News Desk
WFNS Innovation & Technology Committee Announces Partnership with Time Medical International Ventures (India) Pvt Ltd for First-in-Class Medical Technology Innovation
News
May 18, 2026

WFNS Innovation & Technology Committee Announces Partnership with Time Medical International Ventures (India) Pvt Ltd for First-in-Class Medical Technology Innovation

The World Federation of Neurosurgical Societies (WFNS) Innovation & Technology Committee has announced collaboration with Time Medical International Ventures (India) Pvt. Ltd (Time Medical India)., a wholly owned subsidiary of Fischer Medical Ventures Limited, marking a significant milestone in advancing innovation in global neurosurgical care. This marks the first time the Committee has formally partnered […]
Article by: IMT News Desk